Thus, in this report, we have applied a recently developed algorithm for assessing the chemical complementarity between immune receptors and CTAs [8] to assess the relationship between such complementarity and DFS and GBM-related gene expression, with results revealing a novel connection between sphingosine kinase-2 (SPHK2) expression and an apparently failed immune response. Here, SPHK2 is linked to glioblastoma.